Merdad Parsey, Gilead CMO
July 17, 2024 11:27 AM EDTUpdated July 19, 01:42 PM
People
R&D

Gilead chief med­ical of­fi­cer Mer­dad Parsey to leave com­pa­ny ear­ly next year

Lei Lei Wu

News Reporter

Mer­dad Parsey, Gilead’s chief med­ical of­fi­cer, will leave the com­pa­ny at a time when its pipeline has stalled and it’s faced sev­er­al ma­jor stum­bles in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the ...

Benev­o­len­tAI CEO is out af­ter less than a year on the job

Sage shakes up se­nior man­age­ment, slash­es pipeline, sheds 33% of staff

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times